Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Venom is a complex biological secretion produced by various animals, including snakes, scorpions, and spiders, primarily for predation or defense (WHO, 2021). It consists of a sophisticated mixture of proteins, peptides, enzymes, and small molecules that target specific physiological systems, such as the nervous, cardiovascular, or hematological systems (NIH, 2023). While venom itself is not a single therapeutic target, its individual components are extensively studied in pharmacology as leads for drug development or as toxins that must be neutralized (PubMed, 2022). Therapeutic intervention typically involves the use of antivenoms, which are purified antibodies designed to bind and neutralize the specific toxins within the venom. In clinical settings, the primary concern is managing the systemic effects of envenomation and the potential for allergic reactions to the treatment (StatPearls, 2023).
Antivenoms function through passive immunization, utilizing antibodies or antibody fragments (Fab or F(ab')2) to bind and neutralize specific toxins within the venom mixture, thereby preventing their interaction with physiological targets and facilitating their clearance (StatPearls, 2023).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Venom.